Informações:
Falhas:
ID
28679
Descrição
Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism; ODM derived from: https://clinicaltrials.gov/show/NCT01012193
Link
https://clinicaltrials.gov/show/NCT01012193
Palavras-chave
Versões (1)
- 25/01/2018 25/01/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
25 de janeiro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Coronary Artery Disease NCT01012193
Eligibility Coronary Artery Disease NCT01012193
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT01012193
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Coronary Stenosis Percentage
Item
significant coronary artery stenosis (>70% by visual estimate)
boolean
C0242231 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,2])
Coronary stent placement elective
Item
elective coronary stent implantation
boolean
C0948884 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
C0439608 (UMLS CUI [1,2])
Myocardial Infarction
Item
acute myocardial infarction
boolean
C0027051 (UMLS CUI [1])
Hemorrhage | Bleeding tendency
Item
active bleeding and bleeding diatheses
boolean
C0019080 (UMLS CUI [1])
C1458140 (UMLS CUI [2])
C1458140 (UMLS CUI [2])
Hemodynamic instability
Item
hemodynamic instability
boolean
C0948268 (UMLS CUI [1])
Anticoagulation Therapy Oral | Warfarin
Item
oral anticoagulation therapy with warfarin
boolean
C0003281 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0043031 (UMLS CUI [2])
C1527415 (UMLS CUI [1,2])
C0043031 (UMLS CUI [2])
Platelet Glycoprotein IIb/IIIA Inhibitors Use of During Procedure
Item
use of peri-procedural glycoprotein iib/iiia inhibitors
boolean
C1373125 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])
C1524063 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])
Medical contraindication Antiplatelet therapy
Item
contraindication to antiplatelet therapy
boolean
C1301624 (UMLS CUI [1,1])
C1096021 (UMLS CUI [1,2])
C1096021 (UMLS CUI [1,2])
Left ventricular ejection fraction
Item
left ventricular ejection fraction < 30%
boolean
C0428772 (UMLS CUI [1])
White Blood Cell Count procedure | Platelet Count measurement | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
leukocyte count < 3,000/mm3, platelet count < 100,000/mm3, ast or alt ≥ 3 times upper normal
boolean
C0023508 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C0032181 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
Creatinine measurement, serum
Item
serum creatinine level ≥ 3 mg/dl
boolean
C0201976 (UMLS CUI [1])
Cerebrovascular accident
Item
stroke within 3 months
boolean
C0038454 (UMLS CUI [1])
Disease | Exception Heart Diseases | Life Expectancy
Item
noncardiac disease with a life expectancy < 1 year
boolean
C0012634 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
C0023671 (UMLS CUI [3])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
C0023671 (UMLS CUI [3])
Protocol Compliance Unable
Item
inability to follow the protocol
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])